BNP Paribas Financial Markets’s Nutraceutical International Co NUTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-843
Closed -$35.1K 4367
2017
Q2
$35.1K Buy
843
+824
+4,337% +$29.4K ﹤0.01% 3373
2017
Q1
$592 Sell
19
-383
-95% -$13K ﹤0.01% 3820
2016
Q4
$14.1K Sell
402
-210
-34% -$6.65K ﹤0.01% 3315
2016
Q3
$19.1K Buy
612
+290
+90% +$7.47K ﹤0.01% 2919
2016
Q2
$7.45K Buy
+322
New +$7.66K ﹤0.01% 3062
2016
Q1
Sell
-1,612
Closed -$41.6K 3422
2015
Q4
$41.6K Sell
1,612
-181
-10% -$4.45K ﹤0.01% 2937
2015
Q3
$42.3K Buy
1,793
+1,095
+157% +$26.2K ﹤0.01% 2987
2015
Q2
$17.3K Buy
698
+498
+249% +$10.5K ﹤0.01% 3135
2015
Q1
$3.94K Buy
+200
New +$3.76K ﹤0.01% 3270
2014
Q4
Sell
-387
Closed -$8.09K 3780
2014
Q3
$8.09K Buy
+387
New +$9.01K ﹤0.01% 3683
2014
Q2
Sell
-28
Closed -$698 4037
2014
Q1
$698 Sell
28
-100
-78% -$2.59K ﹤0.01% 2966
2013
Q4
$3.43K Buy
+128
New +$3.18K ﹤0.01% 3339

BNP Paribas Financial Markets's NUTR Position: Q3 2017 in Review

BNP Paribas Financial Markets sold out of Nutraceutical International Co (NUTR) in Q3 2017, closing a stake of 843 shares — an estimated $35.1K sold.

BNP Paribas Financial Markets first reported a position in NUTR in Q4 2013 and held it in 12 quarters. The position peaked at $42.3K in Q3 2015. 0 funds tracked by Wall St. Rank hold NUTR as of Q3 2017.

  • BNP Paribas Financial Markets reported no remaining Nutraceutical International Co position as of Q3 2017 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 843 Nutraceutical International Co shares in Q3 2017, an estimated $35.1K.
  • BNP Paribas Financial Markets first reported a position in Nutraceutical International Co in Q4 2013 and held it in 12 quarters.
  • BNP Paribas Financial Markets's Nutraceutical International Co position peaked at $42.3K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q3 2017.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2017, filed 3 Nov 2017.